Accutane is a brand name for isotretinoin, a retinoid medication prescribed for severe, treatment resistant acne. People who take it, or who are starting it, sometimes ask whether it will show up on a pre employment or workplace drug test, or whether it could cause a false positive on a urine screen. This post explains what isotretinoin is, what workplace drug panels actually test for, why isotretinoin is not one of those targets, and why the monthly pregnancy testing required under the drug's safety program is a completely different process from employment drug screening.
Nothing here is medical or legal advice. Anyone with questions about their own prescription, a positive test result, or an employer's policy should talk to their prescribing clinician, the testing program's medical review officer, or an employment attorney.
What isotretinoin is and how it is regulated
Isotretinoin is an oral retinoid, a derivative of vitamin A, approved for severe nodular acne that has not responded to other treatments. Because it causes serious birth defects if taken during pregnancy, the Food and Drug Administration (FDA) requires every isotretinoin product to be dispensed only through a Risk Evaluation and Mitigation Strategy (REMS) program called iPLEDGE. The FDA's own REMS database lists iPLEDGE as a shared system program covering all isotretinoin brands and generics, with required enrollment, counseling, and monthly check ins for patients who can become pregnant. The FDA REMS detail page for the Isotretinoin iPLEDGE program describes the program's elements, including mandatory pregnancy testing, contraception counseling, and pharmacy level verification before each prescription is filled.
The approved prescribing information for isotretinoin, searchable through the National Library of Medicine's DailyMed database, confirms the same point from the label side. DailyMed hosts the official labeling for isotretinoin products, which lists the drug's warnings, the iPLEDGE requirements, and dosing information set by the prescriber. Searching isotretinoin on DailyMed brings up the current labels for the approved brand and generic versions. None of these labels describe isotretinoin as a controlled substance, and it is not scheduled under the federal Controlled Substances Act.
What workplace drug tests actually screen for
Most pre employment and random workplace drug tests use an immunoassay screening panel, commonly a 5 panel, 10 panel, or similar configuration, followed by gas chromatography / mass spectrometry (GC/MS) or liquid chromatography / mass spectrometry (LC/MS) confirmation on any sample that screens positive. These panels are built around specific drug classes: amphetamines, cocaine metabolites, opiates, phencyclidine (PCP), and tetrahydrocannabinol (THC) in a basic panel, with benzodiazepines, barbiturates, methadone, propoxyphene, or other classes added on expanded panels depending on the employer's program.
Isotretinoin is a retinoid, not a stimulant, opioid, cannabinoid, benzodiazepine, or barbiturate, and it does not share a chemical structure or metabolic pathway with any of those drug classes. The National Institutes of Health's MedlinePlus consumer drug information page for isotretinoin describes it strictly as an acne medication with no listed interaction with standard drug screening assays. MedlinePlus's isotretinoin monograph covers how the drug works, its side effects, and required monitoring, none of which involves workplace drug panels. Based on the available published literature and the drug's own labeling, there is no credible cross reactivity evidence connecting isotretinoin to a false positive on any standard immunoassay drug class. If a lab or testing program has specific analyte data suggesting otherwise, that determination belongs to the certifying laboratory and the medical review officer, not to general guidance like this post.
| Panel class typically screened | Does isotretinoin belong to this class |
|---|---|
| Amphetamines / methamphetamine | No |
| Cocaine metabolites | No |
| Opiates / opioids | No |
| THC (cannabinoids) | No |
| PCP | No |
| Benzodiazepines / barbiturates | No |
| Retinoids (isotretinoin's own class) | Not part of any standard workplace panel |
iPLEDGE pregnancy testing is not employment drug testing
A common source of confusion is the monthly testing required under iPLEDGE. Patients who can become pregnant and who are prescribed isotretinoin must complete a monthly pregnancy test as a condition of getting each prescription filled, along with contraception counseling and program enrollment steps documented through the iPLEDGE system. This testing exists solely to prevent fetal exposure to a drug known to cause severe birth defects. It is administered through the patient's prescriber or an affiliated lab, the results go into the iPLEDGE program and the patient's medical record, and the results are not shared with employers, and have no connection to a workplace drug screening program.
Workplace drug testing, by contrast, is typically either a condition of employment under a company policy or, for certain federally regulated positions such as commercial drivers, required under separate federal transportation rules. The two testing systems do not overlap, use different sample types and procedures in most cases, and serve entirely different purposes. An employer running a standard drug screening program will not see, and generally has no legal basis to request, a candidate's iPLEDGE pregnancy test results or prescription history for isotretinoin or any other medication.
What happens if a prescription medication is ever questioned
Because isotretinoin is not targeted by any standard panel, a true positive result attributable to isotretinoin should not occur on a properly confirmed workplace drug test. If any question ever comes up about a result, the standard process is the same regardless of which medication is involved. A nonnegative screening result goes to a medical review officer (MRO), a licensed physician trained to interpret drug test results, who contacts the individual confidentially to ask about current prescriptions and determine whether a legitimate medical explanation accounts for the result. The Substance Abuse and Mental Health Services Administration (SAMHSA) oversees the certification standards, laboratory requirements, and medical review officer process that federally regulated workplace drug testing programs must follow. SAMHSA's workplace programs resources describe how certified laboratories, collection procedures, and the MRO review step fit together in a compliant program. Employers who are not federally mandated often model their own programs on this same structure.
Employees or applicants who take isotretinoin, or any other prescription medication, generally are not required to disclose it in advance of a test. If a question arises after a screen, bringing current prescription documentation to the review conversation with the MRO is the standard way to resolve it. This process exists precisely so that a legitimate prescription does not jeopardize someone's job, and it is handled through the MRO, not through a workplace supervisor or human resources file.
Program design considerations for employers
Employers building or reviewing a drug testing program should remember that isotretinoin and similar dermatology medications are not something a standard panel is designed to catch, and attempting to screen for a non target substance is not an effective use of a testing budget. The more relevant considerations for most employers are which panel configuration fits the job's safety sensitivity, whether the role falls under a federal testing mandate such as the Department of Transportation rules for safety sensitive transportation employees, and how the company's written policy addresses the MRO review and appeal process for any nonnegative result. State law on drug testing procedures, notice requirements, and permissible panel scope varies, so employers should confirm current requirements for their state before finalizing a policy.
Organizations that manage their own collection process, including dip card or test cup based screening, can review bulk supply options through American Screening Corporation's drug test cup collection and through the company's wholesale portal for account based ordering.
Related reading
- Does Methotrexate Show Up on a Drug Test? Immunosuppressants and Panels
- Does Hydroxychloroquine Show Up on a Drug Test? Plaquenil and Panel Screens
Frequently asked questions
Does Accutane show up on a standard drug test panel?
No. Isotretinoin, the generic name for Accutane, is a retinoid acne medication and is not part of any standard workplace drug test panel class such as amphetamines, opiates, THC, PCP, cocaine metabolites, or benzodiazepines.
Can isotretinoin cause a false positive drug test?
There is no credible published cross reactivity evidence linking isotretinoin to a false positive on standard immunoassay drug screens. If a result is ever questioned, the medical review officer process is the way to resolve it with prescription documentation.
Is the iPLEDGE pregnancy test the same as a workplace drug test?
No. iPLEDGE pregnancy testing is a separate FDA required safety program tied to the isotretinoin prescription itself, administered through the prescriber, and it has no connection to employer drug screening and is not shared with employers.
Will my employer find out I am taking Accutane from a drug test?
A standard drug test screens for specific drug classes, not for every medication a person takes, and employers generally do not have access to iPLEDGE records or prescription history through a drug screening program.
What should someone do if a prescription medication is flagged during screening?
Nonnegative results go through a medical review officer, who contacts the individual confidentially to discuss current prescriptions before any result is reported to the employer.
Do all employers have to drug test, and does isotretinoin affect that policy?
Federal law does not require most private employers to drug test, outside of specific federally regulated roles. Isotretinoin use does not change whether or how an employer's program applies, since it is not a target analyte on any standard panel.
This article is general information, not medical or legal advice. Anyone with questions about a specific prescription, test result, or employer policy should consult their healthcare provider, the testing program's medical review officer, or an employment attorney.
